
BRIEF-Vanta Bioscience CEO Sadhanala Venkata Rao Resigns
Jan 4 (Reuters) - Vanta Bioscience Ltd VANB.BO :* VANTA BIOSCIENCE LTD - SADHANALA VENKATA RAO RESIGNS AS CEO...
Jan 4 (Reuters) - Vanta Bioscience Ltd VANB.BO :* VANTA BIOSCIENCE LTD - SADHANALA VENKATA RAO RESIGNS AS CEO...
May 22 (Reuters) - Vanta Bioscience Ltd VANB.BO :* EXPECTS IMPACT OF COVID-19 PANDEMIC WOULD NOT BE TOO SIGNIFICANT FOR CO...
March 10 (Reuters) - Vanta Bioscience Ltd VANB.BO :* APPROVED RE-APPOINTMENT OF DOPESH RAJA MULAKALA AS CO'S...
April 5 (Reuters) - Vanta Bioscience Ltd VANB.BO :* SAYS UNIT SIGNS CRO SERVICE AGREEMENT OF 290 MILLION RUPEES WITH EMCURE PHARMACEUTICALS LIMITED...
July 30 (Reuters) - Vanta Bioscience Ltd VANB.BO :* VANTA BIOSCIENCE LTD EXPANDS INTO CLINICAL RESEARCH* VANTA BIOSCIENCE LTD - CO IS PROJECTING TO ADD REVENUE OF 2.50 BILLION RUPEES IN...
July 24 (Reuters) - Vanta Bioscience Ltd VANB.BO :* SAYS ENTERED EXCLUSIVE SERVICE AGREEMENT WITH HONGKONG THINKWAY TRADING LIMITED FOR CHINA, APAC & LATAM...
July 4 (Reuters) - Vanta Bioscience Ltd VANB.BO :* APPOINTS A. KIRAN KUMAR AS CFO
Jan 5 (Reuters) - Vanta Bioscience Ltd VANB.BO :* SAYS NOTED RESIGNATION OF SADHANALA VENKATA RAO AS CFO* SAYS APPOINTED SADHANALA VENKATA RAO AS CEO...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.